Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia

Abstract

Among Australian adolescents, the 4CMenB vaccine had no discernible effect on the carriage of disease-causing meningococci, including group B. (Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT03089086.).